In Brief
This article was originally published in The Tan Sheet
Executive Summary
Abbott Nutrition eyes U.S. launches
You may also be interested in...
Anthrax MedKit Initiative Could Learn From OTC Studies – NDAC
FDA’s Nonprescription Drugs Advisory Committee recommends the HHS sponsors of an antibiotic MedKit take lessons from OTC drug development. But many advisory panel members at an April 2 meeting did not see clear benefits of allowing home stockpiling of doxycycline to treat anthrax.
Anthrax MedKit Initiative Could Learn From OTC Studies – NDAC
FDA’s Nonprescription Drugs Advisory Committee recommends the HHS sponsors of an antibiotic MedKit take lessons from OTC drug development. But many advisory panel members at an April 2 meeting did not see clear benefits of allowing home stockpiling of doxycycline to treat anthrax.
Abbott Says Nutritionals Can Succeed Without M&A Activity
Abbott Laboratories executives say its nutritionals business is staying put and can succeed without mergers and acquisitions, despite dragging U.S. sales.